Cargando…

Signalling via T cell receptor (TCR) in patients with SLE

Detalles Bibliográficos
Autores principales:	Cebecauer, M, Cebecauer, L, Kozáková, D, Rovenský, J, Lukáè, J, Bartùòková, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273232/ http://dx.doi.org/10.1186/ar229

Ejemplares similares

Elevated anti-serum amyloid P component (SAP) antibodies in SLE patients
por: Zandman-Goddard, G, et al.
Publicado: (2003)

Activation of the Hedgehog signaling pathway in T-lineage cells inhibits TCR repertoire selection in the thymus and peripheral T-cell activation
por: Rowbotham, Nicola J., et al.
Publicado: (2007)

Presence of anti-RNP-A and anti-RNP-C antibodies is inversely associated with renal symptoms of systemic lupus erythematosus
por: Hoffman, I, et al.
Publicado: (2003)

Prolonged stimulation by TNF uncouples T cell receptor (TCR) signalling pathways at many levels
por: Clark, JM, et al.
Publicado: (2002)

False positivity of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus
por: Hoffman, IEA, et al.
Publicado: (2004)

Role of Lipids in Morphogenesis of T-Cell Microvilli
por: Cebecauer, Marek
Publicado: (2021)

B cells at the adaptive-innate immune system interface in SLE
por: Anolik, JH, et al.
Publicado: (2012)

Clinical impact of biologic therapy in the treatment of SLE
por: Wallace, Daniel J
Publicado: (2013)

SLE risk alleles and cell development and activation
por: Kim, SJ, et al.
Publicado: (2012)

T lymphocytes of patients with SLE lack Stat4
por: Aringer, M, et al.
Publicado: (2001)

The role of DNA in the pathogenesis of SLE
por: Pisetsky, DS
Publicado: (2001)

Characterization of RA33 (hnRNP-A2/B1)-autoreactive T cells in SLE-patients
por: Fritsch, R, et al.
Publicado: (2001)

A Tribute to Professor Katharina Gaus
por: Cebecauer, Marek
Publicado: (2021)

PROMISSE: progress in understanding pregnancy complications in patients with SLE
por: Salmon, JE
Publicado: (2012)

SLE: insights from array-based proteomics
por: Wu, T, et al.
Publicado: (2012)

Genetic analysis of the pentraxin genes in SLE
por: Russell, AI, et al.
Publicado: (2001)

Vasculitis and Systemic Lupus Erythematous (SLE)
por: Cortis, Elisabetta, et al.
Publicado: (2015)

The use of Ribomunyl(®) in the immunomodulatory treatment of rats with adjuvant arthritis
por: Rovenský, J, et al.
Publicado: (2001)

Regulatory natural autoantibodies suppress inflammation and SLE disease activity
por: Silverman, GJ, et al.
Publicado: (2012)

Nucleosome binding by serum amyloid P component from SLE patients
por: Heegaard, NHH, et al.
Publicado: (2001)

Immuno-serological profile of Systemic Erythemic Lupus (SLE) patients with neuropsychiatric manifestations (NP)
por: Stojanovich, L, et al.
Publicado: (2001)

Sociodemographic characteristics of SLE patients in a large metropolitan area with a high Afro-Caribbean population
por: Cabas-Vargas, J, et al.
Publicado: (2012)

IRF5 expression profiling in SLE patients: new leads to a pathogenic signature?
por: Barnes, BJ, et al.
Publicado: (2012)

Neuropsychiatric events in SLE: determination of attribution and assessment of outcome
por: Hanly, JG
Publicado: (2012)

Clinical and immunological effects of anti-TNF therapy in systemic lupus erythematosus (SLE)
por: Aringer, M, et al.
Publicado: (2003)

High score on PREDICTS is associated with 10-fold increased odds for the progression of subclinical atherosclerosis in SLE
por: McMahon, M, et al.
Publicado: (2012)

Large-scale test data set for location problems
por: Cebecauer, Matej, et al.
Publicado: (2018)

Editorial: Molecular Organization of Membranes: Where Biology Meets Biophysics
por: Cebecauer, Marek, et al.
Publicado: (2017)

Dual Role of CD4 in Peripheral T Lymphocytes
por: Glatzová, Daniela, et al.
Publicado: (2019)

Impacts of COVID-19 on public transport ridership in Sweden: Analysis of ticket validations, sales and passenger counts
por: Jenelius, Erik, et al.
Publicado: (2020)

Autoantibodies to the TNF-α translational regulators TIA-1 and TIAR occur frequently in sera of patients with SLE and scleroderma
por: Jimenez-Boj, E, et al.
Publicado: (2002)

Redox-sensitive changes in conformation and cellular localization of LAT and downstream TCR signaling lead to hyporesponsiveness of synovial fluid T cells in rheumatoid arthritis
por: Gringhuis, SI, et al.
Publicado: (2001)

Validating the expression of miRNAs in healthy controls and SLE patients and to predict possible gene targets
por: Chugha, Amandeep, et al.
Publicado: (2015)

MicroRNA-3148 modulates differential gene expression of the SLE-associated TLR7 variant
por: Deng, Y, et al.
Publicado: (2012)

Dominance of hydrophobic reading frames in complementarity determining region 3 of variable heavy chain genes from a patient with untreated SLE
por: Yazdani-Biuki, B, et al.
Publicado: (2001)

Interplay of neutrophils and type I interferons in the development of end-organ damage in SLE
por: Kaplan, MJ
Publicado: (2012)

Mycophenolate mofetil prevents the development of a clinical relapse in SLE patients at risk: an open pilot study
por: Bijl, M, et al.
Publicado: (2002)

Impaired T-cell rsponse to subsequent TCR-stimulation after anti-CD3 induced proliferation
por: Köller, MD, et al.
Publicado: (2001)

Production of IFN-α by Natural IFN-α Producing Cells (NIPC), induced by apoptotic cells and autoantibodies via FcγRII, could be a pivotal event in the etiopathogenesis of SLE
por: Rönnblom, LR, et al.
Publicado: (2002)

Comparison of different immunoassays detecting anti-chromatin autoantibodies in systemic lupus erythematosus (SLE)
por: Roux-Lombard, P, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_h28p4jbvl32ou9571lesnabpr2